APO Research
Talk to an analyst

APO RESEARCH · REPORT

Penicillin & Streptomycin

Compare research editions
View pricing & licenses

Selected research

Industry Research

Penicillin & Streptomycin Industry Research Report 2026

20 December 2025145 pages

Choose your research edition.

Industry ResearchPenicillin & Streptomycin Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Penicillin & Streptomycin Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Penicillin & Streptomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Penicillin & Streptomycin Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Penicillin & Streptomycin Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Penicillin & Streptomycin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Penicillin & Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Penicillin & Streptomycin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Penicillin & Streptomycin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Penicillin & Streptomycin include Takeda Pharmaceutical Company, Johnson & Johnson, Novartis, Merck & Co., Roche Pharmaceuticals, Eli Lilly and Co, Pfizer, GlaxoSmithKline and Bayer HealthCare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Penicillin & Streptomycin market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Penicillin & Streptomycin Market by Company

Takeda Pharmaceutical Company

Johnson & Johnson

Novartis

Merck & Co.

Roche Pharmaceuticals

Eli Lilly and Co

Pfizer

GlaxoSmithKline

Bayer HealthCare

Amgen

Astra Zeneca

Toyama Chemical

Sanofi Aventis

MiddleBrook Pharmaceuticals

Gilead Sciences

Celgine Corporation

Bristol Myers Squibb

Biogen IDEC

Astellas Pharma

Abbot Laboratories

Penicillin & Streptomycin Segment by Type

Penicillin

Streptomycin

Penicillin & Streptomycin Segment by Application

Hospitals

Clinics

Others

Penicillin & Streptomycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Penicillin & Streptomycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Penicillin & Streptomycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Penicillin & Streptomycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Penicillin & Streptomycin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Penicillin & Streptomycin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Penicillin & Streptomycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Penicillin & Streptomycin Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Penicillin & Streptomycin Sales (k units) of Manufacturers (2021-2026) Table 7. Global Penicillin & Streptomycin Sales Market Share by Manufacturers (2021-2026) Table 8. Global Penicillin & Streptomycin Revenue of Manufacturers (2021-2026) Table 9. Global Penicillin & Streptomycin Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Penicillin & Streptomycin Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Penicillin & Streptomycin Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Penicillin & Streptomycin, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Penicillin & Streptomycin, Product Type & Application Table 14. Global Penicillin & Streptomycin Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Penicillin & Streptomycin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Takeda Pharmaceutical Company Company Information Table 19. Takeda Pharmaceutical Company Business Overview Table 20. Takeda Pharmaceutical Company Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Takeda Pharmaceutical Company Penicillin & Streptomycin Product Portfolio Table 22. Takeda Pharmaceutical Company Recent Developments Table 23. Johnson & Johnson Company Information Table 24. Johnson & Johnson Business Overview Table 25. Johnson & Johnson Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Johnson & Johnson Penicillin & Streptomycin Product Portfolio Table 27. Johnson & Johnson Recent Developments Table 28. Novartis Company Information Table 29. Novartis Business Overview Table 30. Novartis Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Novartis Penicillin & Streptomycin Product Portfolio Table 32. Novartis Recent Developments Table 33. Merck & Co. Company Information Table 34. Merck & Co. Business Overview Table 35. Merck & Co. Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Merck & Co. Penicillin & Streptomycin Product Portfolio Table 37. Merck & Co. Recent Developments Table 38. Roche Pharmaceuticals Company Information Table 39. Roche Pharmaceuticals Business Overview Table 40. Roche Pharmaceuticals Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Roche Pharmaceuticals Penicillin & Streptomycin Product Portfolio Table 42. Roche Pharmaceuticals Recent Developments Table 43. Eli Lilly and Co Company Information Table 44. Eli Lilly and Co Business Overview Table 45. Eli Lilly and Co Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Eli Lilly and Co Penicillin & Streptomycin Product Portfolio Table 47. Eli Lilly and Co Recent Developments Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Pfizer Penicillin & Streptomycin Product Portfolio Table 52. Pfizer Recent Developments Table 53. GlaxoSmithKline Company Information Table 54. GlaxoSmithKline Business Overview Table 55. GlaxoSmithKline Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. GlaxoSmithKline Penicillin & Streptomycin Product Portfolio Table 57. GlaxoSmithKline Recent Developments Table 58. Bayer HealthCare Company Information Table 59. Bayer HealthCare Business Overview Table 60. Bayer HealthCare Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Bayer HealthCare Penicillin & Streptomycin Product Portfolio Table 62. Bayer HealthCare Recent Developments Table 63. Amgen Company Information Table 64. Amgen Business Overview Table 65. Amgen Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Amgen Penicillin & Streptomycin Product Portfolio Table 67. Amgen Recent Developments Table 68. Astra Zeneca Company Information Table 69. Astra Zeneca Business Overview Table 70. Astra Zeneca Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Astra Zeneca Penicillin & Streptomycin Product Portfolio Table 72. Astra Zeneca Recent Developments Table 73. Toyama Chemical Company Information Table 74. Toyama Chemical Business Overview Table 75. Toyama Chemical Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Toyama Chemical Penicillin & Streptomycin Product Portfolio Table 77. Toyama Chemical Recent Developments Table 78. Sanofi Aventis Company Information Table 79. Sanofi Aventis Business Overview Table 80. Sanofi Aventis Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Sanofi Aventis Penicillin & Streptomycin Product Portfolio Table 82. Sanofi Aventis Recent Developments Table 83. MiddleBrook Pharmaceuticals Company Information Table 84. MiddleBrook Pharmaceuticals Business Overview Table 85. MiddleBrook Pharmaceuticals Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. MiddleBrook Pharmaceuticals Penicillin & Streptomycin Product Portfolio Table 87. MiddleBrook Pharmaceuticals Recent Developments Table 88. Gilead Sciences Company Information Table 89. Gilead Sciences Business Overview Table 90. Gilead Sciences Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Gilead Sciences Penicillin & Streptomycin Product Portfolio Table 92. Gilead Sciences Recent Developments Table 93. Celgine Corporation Company Information Table 94. Celgine Corporation Business Overview Table 95. Celgine Corporation Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Celgine Corporation Penicillin & Streptomycin Product Portfolio Table 97. Celgine Corporation Recent Developments Table 98. Bristol Myers Squibb Company Information Table 99. Bristol Myers Squibb Business Overview Table 100. Bristol Myers Squibb Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Bristol Myers Squibb Penicillin & Streptomycin Product Portfolio Table 102. Bristol Myers Squibb Recent Developments Table 103. Biogen IDEC Company Information Table 104. Biogen IDEC Business Overview Table 105. Biogen IDEC Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Biogen IDEC Penicillin & Streptomycin Product Portfolio Table 107. Biogen IDEC Recent Developments Table 108. Astellas Pharma Company Information Table 109. Astellas Pharma Business Overview Table 110. Astellas Pharma Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Astellas Pharma Penicillin & Streptomycin Product Portfolio Table 112. Astellas Pharma Recent Developments Table 113. Abbot Laboratories Company Information Table 114. Abbot Laboratories Business Overview Table 115. Abbot Laboratories Penicillin & Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Abbot Laboratories Penicillin & Streptomycin Product Portfolio Table 117. Abbot Laboratories Recent Developments Table 118. Global Penicillin & Streptomycin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Penicillin & Streptomycin Sales by Region (2021-2026) & (k units) Table 120. Global Penicillin & Streptomycin Sales Market Share by Region (2021-2026) Table 121. Global Penicillin & Streptomycin Sales by Region (2027-2032) & (k units) Table 122. Global Penicillin & Streptomycin Sales Market Share by Region (2027-2032) Table 123. Global Penicillin & Streptomycin Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Penicillin & Streptomycin Revenue Market Share by Region (2021-2026) Table 125. Global Penicillin & Streptomycin Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Penicillin & Streptomycin Revenue Market Share by Region (2027-2032) Table 127. North America Penicillin & Streptomycin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Penicillin & Streptomycin Sales by Country (2021-2026) & (k units) Table 129. North America Penicillin & Streptomycin Sales by Country (2027-2032) & (k units) Table 130. North America Penicillin & Streptomycin Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Penicillin & Streptomycin Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Penicillin & Streptomycin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Penicillin & Streptomycin Sales by Country (2021-2026) & (k units) Table 134. Europe Penicillin & Streptomycin Sales by Country (2027-2032) & (k units) Table 135. Europe Penicillin & Streptomycin Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Penicillin & Streptomycin Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Penicillin & Streptomycin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Penicillin & Streptomycin Sales by Country (2021-2026) & (k units) Table 139. Asia Pacific Penicillin & Streptomycin Sales by Country (2027-2032) & (k units) Table 140. Asia Pacific Penicillin & Streptomycin Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Penicillin & Streptomycin Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Penicillin & Streptomycin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Penicillin & Streptomycin Sales by Country (2021-2026) & (k units) Table 144. South America Penicillin & Streptomycin Sales by Country (2027-2032) & (k units) Table 145. South America Penicillin & Streptomycin Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Penicillin & Streptomycin Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Penicillin & Streptomycin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Penicillin & Streptomycin Sales by Country (2021-2026) & (k units) Table 149. Middle East and Africa Penicillin & Streptomycin Sales by Country (2027-2032) & (k units) Table 150. Middle East and Africa Penicillin & Streptomycin Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Penicillin & Streptomycin Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Penicillin & Streptomycin Sales by Type (2021-2026) & (k units) Table 153. Global Penicillin & Streptomycin Sales by Type (2027-2032) & (k units) Table 154. Global Penicillin & Streptomycin Sales Market Share by Type (2021-2026) Table 155. Global Penicillin & Streptomycin Sales Market Share by Type (2027-2032) Table 156. Global Penicillin & Streptomycin Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Penicillin & Streptomycin Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Penicillin & Streptomycin Revenue Market Share by Type (2021-2026) Table 159. Global Penicillin & Streptomycin Revenue Market Share by Type (2027-2032) Table 160. Global Penicillin & Streptomycin Price by Type (2021-2026) & (US$/unit) Table 161. Global Penicillin & Streptomycin Price by Type (2027-2032) & (US$/unit) Table 162. Global Penicillin & Streptomycin Sales by Application (2021-2026) & (k units) Table 163. Global Penicillin & Streptomycin Sales by Application (2027-2032) & (k units) Table 164. Global Penicillin & Streptomycin Sales Market Share by Application (2021-2026) Table 165. Global Penicillin & Streptomycin Sales Market Share by Application (2027-2032) Table 166. Global Penicillin & Streptomycin Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Penicillin & Streptomycin Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Penicillin & Streptomycin Revenue Market Share by Application (2021-2026) Table 169. Global Penicillin & Streptomycin Revenue Market Share by Application (2027-2032) Table 170. Global Penicillin & Streptomycin Price by Application (2021-2026) & (US$/unit) Table 171. Global Penicillin & Streptomycin Price by Application (2027-2032) & (US$/unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Penicillin & Streptomycin Distributors List Table 175. Penicillin & Streptomycin Customers List Table 176. Penicillin & Streptomycin Industry Trends Table 177. Penicillin & Streptomycin Industry Drivers Table 178. Penicillin & Streptomycin Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Penicillin & Streptomycin Product Image Figure 5. Global Penicillin & Streptomycin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Penicillin & Streptomycin Market Size (2021-2032) & (US$ Million) Figure 7. Global Penicillin & Streptomycin Sales (2021-2032) & (k units) Figure 8. Global Penicillin & Streptomycin Average Price (US$/unit) & (2021-2032) Figure 9. Penicillin Product Image Figure 10. Streptomycin Product Image Figure 11. Hospitals Product Image Figure 12. Clinics Product Image Figure 13. Others Product Image Figure 14. Global Penicillin & Streptomycin Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Penicillin & Streptomycin, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Penicillin & Streptomycin Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Penicillin & Streptomycin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Penicillin & Streptomycin Sales by Region in 2025 Figure 20. Global Penicillin & Streptomycin Revenue by Region in 2025 Figure 21. North America Penicillin & Streptomycin Market Size by Country in 2025 Figure 22. North America Penicillin & Streptomycin Sales Market Share by Country (2021-2032) Figure 23. North America Penicillin & Streptomycin Revenue Market Share by Country (2021-2032) Figure 24. United States Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Penicillin & Streptomycin Market Size by Country in 2025 Figure 28. Europe Penicillin & Streptomycin Sales Market Share by Country (2021-2032) Figure 29. Europe Penicillin & Streptomycin Revenue Market Share by Country (2021-2032) Figure 30. Germany Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Penicillin & Streptomycin Market Size by Country in 2025 Figure 41. Asia Pacific Penicillin & Streptomycin Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Penicillin & Streptomycin Revenue Market Share by Country (2021-2032) Figure 43. China Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Penicillin & Streptomycin Market Size by Country in 2025 Figure 52. South America Penicillin & Streptomycin Sales Market Share by Country (2021-2032) Figure 53. South America Penicillin & Streptomycin Revenue Market Share by Country (2021-2032) Figure 54. Brazil Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Penicillin & Streptomycin Market Size by Country in 2025 Figure 58. Middle East and Africa Penicillin & Streptomycin Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Penicillin & Streptomycin Revenue Market Share by Country (2021-2032) Figure 60. Egypt Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Penicillin & Streptomycin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Penicillin & Streptomycin Sales Market Share by Type (2021-2032) Figure 66. Global Penicillin & Streptomycin Revenue Market Share by Type (2021-2032) Figure 67. Global Penicillin & Streptomycin Price (US$/unit) by Type (2021-2032) Figure 68. Global Penicillin & Streptomycin Sales Market Share by Application (2021-2032) Figure 69. Global Penicillin & Streptomycin Revenue Market Share by Application (2021-2032) Figure 70. Global Penicillin & Streptomycin Price (US$/unit) by Application (2021-2032) Figure 71. Penicillin & Streptomycin Value Chain Figure 72. Penicillin & Streptomycin Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Penicillin & Streptomycin Industry Opportunities and Challenges

Scope & coverage.

Types
  • Penicillin
  • Streptomycin
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Takeda Pharmaceutical Company
  • Johnson & Johnson
  • Novartis
  • Merck & Co.
  • Roche Pharmaceuticals
  • Eli Lilly and Co
  • Pfizer
  • GlaxoSmithKline
  • Bayer HealthCare
  • Amgen
  • Astra Zeneca
  • Toyama Chemical
  • Sanofi Aventis
  • MiddleBrook Pharmaceuticals
  • Gilead Sciences
  • Celgine Corporation
  • Bristol Myers Squibb
  • Biogen IDEC
  • Astellas Pharma
  • Abbot Laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Penicillin & Streptomycin Market Size (2021-2032)
  4. 2.2.2 Global Penicillin & Streptomycin Sales (2021-2032)
  5. 2.2.3 Global Penicillin & Streptomycin Market Average Price (2021-2032)
  6. 2.3 Penicillin & Streptomycin by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Penicillin
  9. 2.3.3 Streptomycin
  10. 2.4 Penicillin & Streptomycin by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospitals
  13. 2.4.3 Clinics
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Penicillin & Streptomycin Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Penicillin & Streptomycin Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Penicillin & Streptomycin Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Penicillin & Streptomycin Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Penicillin & Streptomycin Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Penicillin & Streptomycin, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Penicillin & Streptomycin, Product Type & Application
  8. 3.8 Global Manufacturers of Penicillin & Streptomycin, Established Date
  9. 3.9 Global Penicillin & Streptomycin Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Takeda Pharmaceutical Company
  2. 4.1.1 Takeda Pharmaceutical Company Company Information
  3. 4.1.2 Takeda Pharmaceutical Company Business Overview
  4. 4.1.3 Takeda Pharmaceutical Company Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Takeda Pharmaceutical Company Penicillin & Streptomycin Product Portfolio
  6. 4.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 4.2 Johnson & Johnson
  8. 4.2.1 Johnson & Johnson Company Information
  9. 4.2.2 Johnson & Johnson Business Overview
  10. 4.2.3 Johnson & Johnson Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Johnson & Johnson Penicillin & Streptomycin Product Portfolio
  12. 4.2.5 Johnson & Johnson Recent Developments
  13. 4.3 Novartis
  14. 4.3.1 Novartis Company Information
  15. 4.3.2 Novartis Business Overview
  16. 4.3.3 Novartis Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Novartis Penicillin & Streptomycin Product Portfolio
  18. 4.3.5 Novartis Recent Developments
  19. 4.4 Merck & Co.
  20. 4.4.1 Merck & Co. Company Information
  21. 4.4.2 Merck & Co. Business Overview
  22. 4.4.3 Merck & Co. Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Merck & Co. Penicillin & Streptomycin Product Portfolio
  24. 4.4.5 Merck & Co. Recent Developments
  25. 4.5 Roche Pharmaceuticals
  26. 4.5.1 Roche Pharmaceuticals Company Information
  27. 4.5.2 Roche Pharmaceuticals Business Overview
  28. 4.5.3 Roche Pharmaceuticals Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Roche Pharmaceuticals Penicillin & Streptomycin Product Portfolio
  30. 4.5.5 Roche Pharmaceuticals Recent Developments
  31. 4.6 Eli Lilly and Co
  32. 4.6.1 Eli Lilly and Co Company Information
  33. 4.6.2 Eli Lilly and Co Business Overview
  34. 4.6.3 Eli Lilly and Co Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Eli Lilly and Co Penicillin & Streptomycin Product Portfolio
  36. 4.6.5 Eli Lilly and Co Recent Developments
  37. 4.7 Pfizer
  38. 4.7.1 Pfizer Company Information
  39. 4.7.2 Pfizer Business Overview
  40. 4.7.3 Pfizer Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pfizer Penicillin & Streptomycin Product Portfolio
  42. 4.7.5 Pfizer Recent Developments
  43. 4.8 GlaxoSmithKline
  44. 4.8.1 GlaxoSmithKline Company Information
  45. 4.8.2 GlaxoSmithKline Business Overview
  46. 4.8.3 GlaxoSmithKline Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 GlaxoSmithKline Penicillin & Streptomycin Product Portfolio
  48. 4.8.5 GlaxoSmithKline Recent Developments
  49. 4.9 Bayer HealthCare
  50. 4.9.1 Bayer HealthCare Company Information
  51. 4.9.2 Bayer HealthCare Business Overview
  52. 4.9.3 Bayer HealthCare Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Bayer HealthCare Penicillin & Streptomycin Product Portfolio
  54. 4.9.5 Bayer HealthCare Recent Developments
  55. 4.10 Amgen
  56. 4.10.1 Amgen Company Information
  57. 4.10.2 Amgen Business Overview
  58. 4.10.3 Amgen Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Amgen Penicillin & Streptomycin Product Portfolio
  60. 4.10.5 Amgen Recent Developments
  61. 4.11 Astra Zeneca
  62. 4.11.1 Astra Zeneca Company Information
  63. 4.11.2 Astra Zeneca Business Overview
  64. 4.11.3 Astra Zeneca Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Astra Zeneca Penicillin & Streptomycin Product Portfolio
  66. 4.11.5 Astra Zeneca Recent Developments
  67. 4.12 Toyama Chemical
  68. 4.12.1 Toyama Chemical Company Information
  69. 4.12.2 Toyama Chemical Business Overview
  70. 4.12.3 Toyama Chemical Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Toyama Chemical Penicillin & Streptomycin Product Portfolio
  72. 4.12.5 Toyama Chemical Recent Developments
  73. 4.13 Sanofi Aventis
  74. 4.13.1 Sanofi Aventis Company Information
  75. 4.13.2 Sanofi Aventis Business Overview
  76. 4.13.3 Sanofi Aventis Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Sanofi Aventis Penicillin & Streptomycin Product Portfolio
  78. 4.13.5 Sanofi Aventis Recent Developments
  79. 4.14 MiddleBrook Pharmaceuticals
  80. 4.14.1 MiddleBrook Pharmaceuticals Company Information
  81. 4.14.2 MiddleBrook Pharmaceuticals Business Overview
  82. 4.14.3 MiddleBrook Pharmaceuticals Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 MiddleBrook Pharmaceuticals Penicillin & Streptomycin Product Portfolio
  84. 4.14.5 MiddleBrook Pharmaceuticals Recent Developments
  85. 4.15 Gilead Sciences
  86. 4.15.1 Gilead Sciences Company Information
  87. 4.15.2 Gilead Sciences Business Overview
  88. 4.15.3 Gilead Sciences Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Gilead Sciences Penicillin & Streptomycin Product Portfolio
  90. 4.15.5 Gilead Sciences Recent Developments
  91. 4.16 Celgine Corporation
  92. 4.16.1 Celgine Corporation Company Information
  93. 4.16.2 Celgine Corporation Business Overview
  94. 4.16.3 Celgine Corporation Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Celgine Corporation Penicillin & Streptomycin Product Portfolio
  96. 4.16.5 Celgine Corporation Recent Developments
  97. 4.17 Bristol Myers Squibb
  98. 4.17.1 Bristol Myers Squibb Company Information
  99. 4.17.2 Bristol Myers Squibb Business Overview
  100. 4.17.3 Bristol Myers Squibb Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Bristol Myers Squibb Penicillin & Streptomycin Product Portfolio
  102. 4.17.5 Bristol Myers Squibb Recent Developments
  103. 4.18 Biogen IDEC
  104. 4.18.1 Biogen IDEC Company Information
  105. 4.18.2 Biogen IDEC Business Overview
  106. 4.18.3 Biogen IDEC Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Biogen IDEC Penicillin & Streptomycin Product Portfolio
  108. 4.18.5 Biogen IDEC Recent Developments
  109. 4.19 Astellas Pharma
  110. 4.19.1 Astellas Pharma Company Information
  111. 4.19.2 Astellas Pharma Business Overview
  112. 4.19.3 Astellas Pharma Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Astellas Pharma Penicillin & Streptomycin Product Portfolio
  114. 4.19.5 Astellas Pharma Recent Developments
  115. 4.20 Abbot Laboratories
  116. 4.20.1 Abbot Laboratories Company Information
  117. 4.20.2 Abbot Laboratories Business Overview
  118. 4.20.3 Abbot Laboratories Penicillin & Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Abbot Laboratories Penicillin & Streptomycin Product Portfolio
  120. 4.20.5 Abbot Laboratories Recent Developments
5 Global Penicillin & Streptomycin Market Scenario by Region
  1. 5.1 Global Penicillin & Streptomycin Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Penicillin & Streptomycin Sales by Region: 2021-2032
  3. 5.2.1 Global Penicillin & Streptomycin Sales by Region: 2021-2026
  4. 5.2.2 Global Penicillin & Streptomycin Sales by Region: 2027-2032
  5. 5.3 Global Penicillin & Streptomycin Revenue by Region: 2021-2032
  6. 5.3.1 Global Penicillin & Streptomycin Revenue by Region: 2021-2026
  7. 5.3.2 Global Penicillin & Streptomycin Revenue by Region: 2027-2032
  8. 5.4 North America Penicillin & Streptomycin Market Facts & Figures by Country
  9. 5.4.1 North America Penicillin & Streptomycin Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Penicillin & Streptomycin Sales by Country (2021-2032)
  11. 5.4.3 North America Penicillin & Streptomycin Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Penicillin & Streptomycin Market Facts & Figures by Country
  16. 5.5.1 Europe Penicillin & Streptomycin Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Penicillin & Streptomycin Sales by Country (2021-2032)
  18. 5.5.3 Europe Penicillin & Streptomycin Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Penicillin & Streptomycin Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Penicillin & Streptomycin Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Penicillin & Streptomycin Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Penicillin & Streptomycin Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Penicillin & Streptomycin Market Facts & Figures by Country
  41. 5.7.1 South America Penicillin & Streptomycin Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Penicillin & Streptomycin Sales by Country (2021-2032)
  43. 5.7.3 South America Penicillin & Streptomycin Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Penicillin & Streptomycin Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Penicillin & Streptomycin Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Penicillin & Streptomycin Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Penicillin & Streptomycin Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Penicillin & Streptomycin Sales by Type (2021-2032)
  2. 6.1.1 Global Penicillin & Streptomycin Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Penicillin & Streptomycin Sales Market Share by Type (2021-2032)
  4. 6.2 Global Penicillin & Streptomycin Revenue by Type (2021-2032)
  5. 6.2.1 Global Penicillin & Streptomycin Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Penicillin & Streptomycin Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Penicillin & Streptomycin Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Penicillin & Streptomycin Sales by Application (2021-2032)
  2. 7.1.1 Global Penicillin & Streptomycin Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Penicillin & Streptomycin Sales Market Share by Application (2021-2032)
  4. 7.2 Global Penicillin & Streptomycin Revenue by Application (2021-2032)
  5. 7.2.1 Global Penicillin & Streptomycin Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Penicillin & Streptomycin Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Penicillin & Streptomycin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Penicillin & Streptomycin Value Chain Analysis
  2. 8.1.1 Penicillin & Streptomycin Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Penicillin & Streptomycin Production Mode & Process
  5. 8.2 Penicillin & Streptomycin Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Penicillin & Streptomycin Distributors
  8. 8.2.3 Penicillin & Streptomycin Customers
9 Global Penicillin & Streptomycin Analyzing Market Dynamics
  1. 9.1 Penicillin & Streptomycin Industry Trends
  2. 9.2 Penicillin & Streptomycin Industry Drivers
  3. 9.3 Penicillin & Streptomycin Industry Opportunities and Challenges
  4. 9.4 Penicillin & Streptomycin Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst